Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

The controversy over whether new businesses can be entitled to lost profits has long been debated among courts, legal counsel, and forensic accounting analysts. In fact, until recently, many courts ...

Companies wanted 2023 to bring certainty on sustainability disclosures and regulations. They didn’t get it. Instead, they continue to wait for an array of new and developing rules, including a climate ...

Based on the EURAMET Calibration Guide No. 18 “Guidelines on the Calibration of Non-Automatic Weighing Instruments” 1–3 (represented as “EURAMET cg-18”), this QApp function offers a dynamic display of ...